Search
Search Results
##search.searchResults.foundPlural##
-
ROLE OF CYTOKINES AS MOLECULAR MARKER OF DENGUE SEVERITY
3260PDF: 1202HTML: 489 -
THE PROTHROMBOTIC STATE ASSOCIATED WITH SARS-COV-2 INFECTION: PATHOPHYSIOLOGICAL ASPECTS COVID and Thrombosis
2230PDF: 845HTML: 443 -
LYMPHOCYTES IN PATIENTS WITH CHRONIC ACTIVE EPSTEIN-BARR VIRUS INFECTION EXHIBITED ELEVATED PD-1/PD-L1 EXPRESSION AND A PREVAILING TH2 IMMUNE RESPONSE. EPSTEIN-BARR VIRUS INFECTION EXHIBITED ELEVATED PD-1/PD-L1
2951PDF: 1134HTML: 127 -
SARS-CoV-2 INFECTED PATIENTS: FROM A HEMATOLOGIST PERSPECTIVE COVID-19 and Hematology
1252PDF: 987HTML: 438 -
TOXICITIES ASSOCIATED WITH CAR-T CELL THERAPIES CAR-T Cell Toxicity
2471PDF: 1712HTML: 470 -
PATHOGENESIS OF MALARIA IN TISSUES AND BLOOD
4647PDF: 1975HTML: 18090 -
BONE MARROW MICROENVIRONMENT INVOLVEMENT IN T-MN: FOCUS ON MESENCHYMAL STEM CELLS MESENCHYMAL STEM CELL IN T-MN
1921PDF: 1030HTML: 223 -
PATHOGENESIS AND TREATMENT OF THROMBOHEMORRHAGIC DIATHESIS IN ACUTE PROMYELOCYTIC LEUKEMIA
1879PDF: 842HTML: 10346Figures 1,2,3: 209 -
-
NEW STRATEGIES FOR STEM CELL MOBILIZATION
2522PDF: 901HTML: 2562 -
-
FAMILIAL MEDITERRANEAN FEVER AND HYPERCOAGULABILITY
1260PDF: 733HTML: 1256 -
-
CD48 AS A NOVEL EARLY BIOMARKER COMPLEMENTING PROCALCITONIN AND LACTATE FOR PREDICTING BACTEREMIA IN PEDIATRIC FEBRILE NEUTROPENIA: A PROSPECTIVE COHORT STUDY CD48 A NOVEL EARLY BIOMARKER PREDICTING BACTERIEMIA
997PDF: 767HTML: 123 -
-
FROM LEGACY TO INNOVATION: PIDOTIMOD’S EXPANDING THERAPEUTIC HORIZON Pidotimod: Revisiting a Classic Immunomodulator
2978PDF: 1044HTML: 970 -
LYMPHOPROLIFERATIVE SYNDROMES ASSOCIATED WITH HUMAN HERPESVIRUS-6A AND HUMAN HERPESVIRUS-6B
3834PDF: 1628HTML: 832Figures . Eliassian: 245 -
TOLL-LIKE RECEPTORS IN CHRONIC LYMPHOCYTIC LEUKEMIA
2656PDF: 906HTML: 17592Fig1 Caligaris: 197Fig.2 Caliga: 242 -
MOLECULAR MECHANISMS OF INHIBITOR DEVELOPMENT IN HEMOPHILIA Guest Editor: Giancarlo Costaman
3466PDF: 1650HTML: 642 -
EBV-RELATED LYMPHOPROLIFERATIVE DISEASES: A REVIEW IN LIGHT OF NEW CLASSIFICATIONS EBV-RELATED LYMPHOPROLIFERATIVE DISEASES
4559PDF: 1765HTML: 1191 -
HIGHLIGHTS ON THE CONTRIBUTION OF GUT MICROBIOTA TO IMMUNE-MEDIATED DISEASES IN CHILDHOOD Gut microbiota in childhood immune-mediated diseases
1142PDF: 815HTML: 176 -
CAR-T CELL THERAPY IN LARGE B CELL LYMPHOMA CAR-T; Large B Cell Lymphoma; Salvage Therapy,
3824PDF: 1518HTML: 329 -
CORD BLOOD PLATELET LYSATE: IN VITRO EVALUATION TO SUPPORT THE USE IN REGENERATIVE MEDICINE. Cord and adult blood platelet lysates
2113PDF: 1177HTML: 271 -
-
PROGNOSTIC FACTORS IN HODGKIN LYMPHOMA
3435PDF: 2021HTML: 7572 -
ULTRASOUND AS FIRST LINE STEP IN ANAEMIA DIAGNOSTICS
1478PDF: 912HTML: 1938 -
DIAGNOSTIC VALUE OF SIMULTANEOUS MEASUREMENT OF PROCALCITONIN, INTERLEUKIN-6 AND HS CRP IN PREDICTION OF EARLY-ONSET NEONATAL SEPSIS
2114PDF: 1254HTML: 1944Untitled: 164TaBles Neinates sepsis: 200 -
Monocyte HLA-Dr Expression to Monitor Immune Response and Potential Infection Risks Following Vaso-Occlusive Crises in Patients with Sickle Cell Anemia Monocyte HLA-DR expression in SCA patients
769PDF: 580HTML: 280 -
Guest Editor: Pellegrino Musto BISPECIFIC ANTIBODIES AND CAR T IN MULTIPLE MYELOMA: APPROPRIATE SELECTION OF PATIENTS AND SEQUENCING BISPECIFIC ANTIBODIES AND CAR T IN MULTIPLE MYELOMA
1754PDF: 1305HTML: 577 -
HEPATITIS C VIRUS INFECTION AND LYMPHOMA
1085PDF: 575HTML: 7881 -
CONCISE REVIEW ON THE FREQUENCY, MAJOR RISK FACTORS AND SURVEILLANCE OF HEPATOCELLULAR CARCINOMA (HCC) IN ?-THALASSEMIAS: PAST, PRESENT AND FUTURE PERSPECTIVES Thalassaemia transfusion dependent, Hepatitis C, hepatocarcinoma.
4359PDF: 1553HTML: 465







